Pascoe Vale, Australia

Andrew James Pow

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • St. Kilda, AU (2013)
  • Pascoe Vale, AU (2020)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Andrew James Pow

Introduction

Andrew James Pow, a distinguished inventor based in Pascoe Vale, Australia, has made significant contributions to the field of biotechnology. With a total of two patents to his name, Pow's innovations focus on the development of antibodies that can combat various health conditions by targeting specific proteins.

Latest Patents

Andrew Pow's latest patents reveal a strong emphasis on advancements in the realm of antibodies. The first patent, titled "Antibodies against TL1a and uses thereof," describes TNF-like ligand 1a (TL1a)-binding proteins with the ability to bind specifically to TL1a and inhibit its interaction with Death Receptor 3 (DR3), while sparing its interaction with Decoy Receptor 3 (DcR3). This innovative approach highlights the potential therapeutic applications of these TL1a-binding proteins in biomedical research.

His second patent, "Anti-IL-12/IL-23 antibodies," presents an antibody that targets human IL-12 and IL-23. This invention binds to both human IL-12p40, existing as a monomer, and human IL-12p80 as a homodimer, effectively inhibiting their respective bindings to human IL-12R β2 and human IL-23R, while not affecting other related receptors. This dual-targeting strategy illustrates a significant step forward in antibody-based treatments.

Career Highlights

Throughout his career, Andrew Pow has been associated with notable companies such as Cephalon Australia Pty. Ltd. and Teva Pharmaceuticals Australia Pty Ltd. His work in these organizations has contributed to his expertise and has played a role in the development of his patented inventions.

Collaborations

Collaboration is an essential aspect of innovation, and Andrew has had the pleasure of working alongside talented individuals, including Adam Clarke and Anthony Gerard Doyle. Their joint efforts in various projects showcase the importance of teamwork in advancing scientific research and developing groundbreaking solutions.

Conclusion

Andrew James Pow is a notable inventor making strides in the field of biotechnology with his innovative work on antibodies. His two patents reflect his ability to address complex biological interactions and offer potential therapeutic applications. As he continues to collaborate and push the boundaries of scientific research, his contributions hold promise for the future of medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…